Preoperative Cervical Epidural Steroid Injection Within Three Months of ACDF Is Associated with Increased Long-Term Pseudoarthrosis and Reoperation Rates: A Propensity Matched Retrospective Analysis

Study DesignRetrospective Cohort Analysis.ObjectiveA mainstay in the nonoperative management of symptomatic degenerative cervical spondylosis (DCS) remains cervical epidural corticosteroid injections (CESI). Given the increasing burden of DCS and the resultant number of patients likely to receive CESI before ACDF, it is integral to clarify the implications of these injections. The objective of the present study was to clarify the associations between preoperative CESI and postoperative outcomes amongst ACDF patients.MethodsA retrospective cohort study was conducted using the TriNetX database. Patients undergoing ACDF were identified and stratified by preoperative CESI exposure. After 1:1 propensity score matching for demographics and comorbidities, 1,193 patients remained in each cohort. The primary outcome was a coded diagnosis of pseudarthrosis after fusion or arthrodesis; secondary outcomes were new-onset cervicalgia, new-onset cervical disc displacement, surgical site infection, and all-cause coded cervical reoperation.ResultsIn those patients exposed to CESI within 3 months of ACDF at 1, 3, and 5 years postoperatively, elevated rates of pseudoarthrosis (13.33% vs. 8.72%, RR 1.53, 95% CI 1.21-1.93, p < 0.001) and new onset cervicalgia (35.42% vs. 23.52%, RR 1.51, 95% CI, p = 0.001) were found. Reoperation rates were significantly higher in the injection group at 5 years (3.86% vs. 2.18%, RR 1.77, 95% CI 1.10-2.84, p = 0.018). No significant differences were noted among patients injected 3-6 months, 6 months to 1 year, and those injected more than 1 year before ACDF.ConclusionsCESI performed within three months of ACDF was associated with higher rates of pseudoarthrosis and of subsequent cervical reoperation.

Authors

Institutions

Publication Details

Journal
Global Spine Journal
Published
2026-11-18
DOI
https://doi.org/10.1177/21925682261511575
Primary Topic
Cervical and Thoracic Myelopathy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Preoperative Cervical Epidural Steroid Injection Within Three Months of ACDF Is Associated with Increased Long-Term Pseudoarthrosis and Reoperation Rates: A Propensity Matched Retrospective Analysis

Gregory Douglas Schroeder, Barrett R. Woods, Ruchir Nanavati, Christopher K. Kepler et al.
2 links
Global Spine Journal
Cervical and Thoracic Myelopathy
article

Preoperative Cervical Epidural Steroid Injection Within Three Months of ACDF Is Associated with Increased Long-Term Pseudoarthrosis and Reoperation Rates: A Propensity Matched Retrospective Analysis

Gregory Douglas Schroeder, Barrett R. Woods, Ruchir Nanavati, Christopher K. Kepler, Matthew Meade, William T. DiCiurcio, Nithin K. Gupta, John Pignataro, Omar I. Sbaih, Mark Miller, Hunter Smith
article en

Abstract

Study DesignRetrospective Cohort Analysis.ObjectiveA mainstay in the nonoperative management of symptomatic degenerative cervical spondylosis (DCS) remains cervical epidural corticosteroid injections (CESI). Given the increasing burden of DCS and the resultant number of patients likely to receive CESI before ACDF, it is integral to clarify the implications of these injections. The objective of the present study was to clarify the associations between preoperative CESI and postoperative outcomes amongst ACDF patients.MethodsA retrospective cohort study was conducted using the TriNetX database. Patients undergoing ACDF were identified and stratified by preoperative CESI exposure. After 1:1 propensity score matching for demographics and comorbidities, 1,193 patients remained in each cohort. The primary outcome was a coded diagnosis of pseudarthrosis after fusion or arthrodesis; secondary outcomes were new-onset cervicalgia, new-onset cervical disc displacement, surgical site infection, and all-cause coded cervical reoperation.ResultsIn those patients exposed to CESI within 3 months of ACDF at 1, 3, and 5 years postoperatively, elevated rates of pseudoarthrosis (13.33% vs. 8.72%, RR 1.53, 95% CI 1.21-1.93, p < 0.001) and new onset cervicalgia (35.42% vs. 23.52%, RR 1.51, 95% CI, p = 0.001) were found. Reoperation rates were significantly higher in the injection group at 5 years (3.86% vs. 2.18%, RR 1.77, 95% CI 1.10-2.84, p = 0.018). No significant differences were noted among patients injected 3-6 months, 6 months to 1 year, and those injected more than 1 year before ACDF.ConclusionsCESI performed within three months of ACDF was associated with higher rates of pseudoarthrosis and of subsequent cervical reoperation.

Global Spine Journal
New England Baptist Hospital (US), Georgetown University (US), Thomas Jefferson University Hospital (US), Rothman Orthopaedics (US)
Good health and well-being
Cervical and Thoracic Myelopathy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon